Effectiveness of Solifenacin versus Mirabegron in the Treatment of Overactive Bladder: A Prospective Cohort Study
Introduction: Overactive Bladder (OAB) syndrome is a symptom-complex defined as urinary urgency, usually accompanied by increased daytime frequency and nocturia, with or without urgency incontinence, in the absence of urinary tract infection or other obvious pathology. Aim: To compare the efficacy...
Saved in:
| Main Authors: | Shyamali Dutta, Korlapally Divya Bhavani, Avik Das, Debadrita Das, Palash Mazumder |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
JCDR Research and Publications Private Limited
2025-07-01
|
| Series: | Journal of Clinical and Diagnostic Research |
| Subjects: | |
| Online Access: | https://jcdr.net/article_fulltext.asp?issn=0973-709x&year=2025&month=July&volume=19&issue=7&page=QC14-QC17&id=21268 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mirabegron nighttime versus daytime dosing for women with overactive bladder syndrome: a randomized controlled trial
by: Sheng-Mou Hsiao
Published: (2025-08-01) -
Acupuncture combined with mirabegron is efficacious for the treatment of overactive bladder: a prospective randomized controlled trial
by: Deng Xiaolin, et al.
Published: (2025-07-01) -
Treatment of overactive bladder symptoms in women with Diunorm®: preliminary results report
by: S. V. Shkodkin, et al.
Published: (2021-07-01) -
Guidelines for the Treatment of Urinary Incontineence and Overactive Bladder
by: C.F. Heyns, et al.
Published: (2002-03-01) -
How to choose appropriate medication for overactive bladder: Findings from the largest integrated clinical trial database analysis of mirabegron studies
by: Hann-Chorng Kuo
Published: (2022-01-01)